Dabigatran is a direct oral anticoagulant (DOAC) that helps prevent blood clots from forming in the body. It is frequently prescribed to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, and is also indicated for the treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE).

Apixaban is a direct oral anticoagulant (DOAC) used to prevent and treat blood clots. It is highly effective in reducing the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, and is also used for the treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE).

Warfarin is a widely used oral anticoagulant (blood thinner) that prevents the formation and growth of blood clots. It is commonly prescribed for patients with atrial fibrillation, deep vein thrombosis (DVT), pulmonary embolism (PE), or those with artificial heart valves to prevent stroke and heart attacks.